Because of the known function of CYP4V2 as a selective omega-hydroxylase of both saturated and polyunsaturated medium-chain fatty acids in humans [17,18], attention on both human and mice models has centered on the role of fatty acid metabolism in the pathogenesis of BCD. This evidence concerns the gene CYP4V2 and Bietti crystalline dystrophy.